Abcam plc statement on dr. jonathan milner's announcement

Cambridge, england & waltham, mass.--(business wire)--abcam plc (nasdaq: abcm) (“abcam” or the “company”), notes today's announcement by dr. jonathan milner. the company considers it surprising that dr. milner has taken active steps to oppose the deal without reviewing the full details in the scheme circular to be published in connection with the proposed acquisition of all of the outstanding shares of abcam by danaher corporation (“danaher”) for $24.00 per share in cash (the “transaction”), wh.
ABCM Ratings Summary
ABCM Quant Ranking